Your cart
Your cart is empty.HEALTH NEWS
Study Title:
Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barr
Study Abstract
Arabinogalactan Alleviates Lipopolysaccharide-Induced Intestinal Epithelial Barrier Damage through Adenosine Monophosphate-Activated Protein Kinase/Silent Information Regulator 1/Nuclear Factor Kappa-B Signaling Pathways in Caco-2 Cells.
Study Information
Int J Mol Sci. 2023 Oct 19;24(20):15337. doi: 10.3390/ijms242015337. PMID: 37895018; PMCID: PMC10607795.
Full Study
https://pubmed.ncbi.nlm.nih.gov/37895018/Recent News
Pterostilbene: A Timeless Health Tonic for Longevity and Vitality
Astaxanthin for Healthier, Hydrated, and Resilient Skin
Arabinogalactan Boosts Lymph Flow and Immunity
Protect Your Gut Mucosal Barrier for Immune Health and Vitality
The Truth About Sugar Substitutes: Are Stevia, Sucralose, and Saccharin Safe?